ClariVest Asset Management’s Accendra Health ACH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-179
Closed -$8K 743
2022
Q1
$8K Hold
179
﹤0.01% 508
2021
Q4
$8K Hold
179
﹤0.01% 551
2021
Q3
$6K Hold
179
﹤0.01% 559
2021
Q2
$8K Sell
179
-41,000
-100% -$1.6M ﹤0.01% 536
2021
Q1
$1.55M Buy
41,179
+1,894
+5% +$59.2K 0.05% 233
2020
Q4
$1.06M Sell
39,285
-784
-2% -$20.2K 0.04% 269
2020
Q3
$1.01M Sell
40,069
-2,817
-7% -$41.1K 0.03% 300
2020
Q2
$327K Buy
42,886
+41,600
+3,235% +$304K 0.01% 467
2020
Q1
$12K Hold
1,286
﹤0.01% 504
2019
Q4
$7K Buy
1,286
+352
+38% +$2.26K ﹤0.01% 518
2019
Q3
$5K Buy
+934
New +$4.19K ﹤0.01% 576

Other funds holding ACH

ClariVest Asset Management's ACH Position: Q2 2022 in Review

ClariVest Asset Management sold out of Accendra Health (ACH) in Q2 2022, closing a stake of 179 shares — an estimated $8K sold.

ClariVest Asset Management first reported a position in ACH in Q3 2019 and held it in 11 quarters. The position peaked at $1.55M in Q1 2021. 251 funds tracked by Wall St. Rank hold ACH as of Q2 2022.

  • ClariVest Asset Management reported no remaining Accendra Health position as of Q2 2022 after selling out during the quarter.
  • ClariVest Asset Management sold 179 Accendra Health shares in Q2 2022, an estimated $8K.
  • ClariVest Asset Management first reported a position in Accendra Health in Q3 2019 and held it in 11 quarters.
  • ClariVest Asset Management's Accendra Health position peaked at $1.55M in Q1 2021.
  • 251 funds tracked by Wall St. Rank held Accendra Health as of Q2 2022.

Based on ClariVest Asset Management's 13F filing for Q2 2022, filed 12 Aug 2022.